Literature DB >> 9176019

Adrenomedullin: a hypotensive hormone in man.

J G Lainchbury1, G J Cooper, D H Coy, N Y Jiang, L K Lewis, T G Yandle, A M Richards, M G Nicholls.   

Abstract

1. Adrenomedullin, a recently discovered 52-amino-acid peptide hormone, circulates in plasma at low picomolar levels in man. Animal studies and studies in vitro indicate that it has diverse biological actions, including vasodilatation, natriuresis and diuresis, and positive inotropism as well as anti-proliferative effects. We investigated the bioactivity of two doses of adrenomedullin in healthy human subjects. 2. Human adrenomedullin was given intravenously to eight male subjects at 2 and 8 ng min-1 kg-1, and haemodynamic, hormonal, renal and biochemical responses were recorded in a placebo (vehicle)-controlled, randomized study. 3. Compared with vehicle, adrenomedullin reduced mean arterial pressure (P = 0.05 for duration of infusion, mean difference at end of infusion 7.7 mmHg), systolic arterial pressure (P = 0.04 for duration of infusion, mean difference at end of infusion 10.7 mmHg) and at the lower dose reduced diastolic arterial pressure (P = 0.05 for lower dose, mean difference at end of infusion 6.3 mmHg) in the absence of compensatory responses in sympathetic activity or renin release. Urine volume and electrolyte excretion were unaffected. 4. The threshold for biological activity of adrenomedullin in man is lower, for arterial pressure than for renal or hormonal responses, and is evident at plasma concentrations seen in disorders of the circulation. Adrenomedullin may be an important hormone under pathophysiological circumstances.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176019     DOI: 10.1042/cs0920467

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  15 in total

Review 1.  Adrenal medulla.

Authors:  J D Greifenkamp; D J DiPette
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

Review 2.  Effects of omapatrilat on pharmacodynamic biomarkers of neutral endopeptidase and Angiotensin-converting enzyme activity in humans.

Authors:  O Vesterqvist; R A Reeves
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 3.  Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?

Authors:  Mihael Potocki; Ronny Ziller; Christian Mueller
Journal:  Curr Heart Fail Rep       Date:  2012-09

Review 4.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

5.  A role for adrenomedullin as a pain-related peptide in the rat.

Authors:  Weiya Ma; Jean-Guy Chabot; Remi Quirion
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

Review 6.  From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides.

Authors:  Aitor Blanco-Míguez; Alberto Gutiérrez-Jácome; Martín Pérez-Pérez; Gael Pérez-Rodríguez; Sandra Catalán-García; Florentino Fdez-Riverola; Anália Lourenço; Borja Sánchez
Journal:  Protein Sci       Date:  2016-04-19       Impact factor: 6.725

7.  Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP).

Authors:  I B Wilkinson; C M McEniery; K H Bongaerts; H MacCallum; D J Webb; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

8.  Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.

Authors:  J B Pawlak; S E Wetzel-Strong; M K Dunn; K M Caron
Journal:  Peptides       Date:  2016-12-08       Impact factor: 3.750

Review 9.  Biomarkers in acute myocardial infarction.

Authors:  Daniel Chan; Leong L Ng
Journal:  BMC Med       Date:  2010-06-07       Impact factor: 8.775

10.  Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males.

Authors:  Kathleen Caron; John Hagaman; Toshio Nishikimi; Hyung-Suk Kim; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.